DPC
Dr Patrice Cristofini
REGEnLife
CEO
Description
Dr. Patrice Cristofini is a multifaceted professional in the healthcare industry, currently serving as the CEO and General Manager of REGEnLIFE, a French medtech company focused on developing innovative treatments for neurodegenerative diseases.
With a strong medical background, Dr. Cristofini is a former intern at Paris hospitals and holds a diploma from ESSEC in international management of healthcare structures. His expertise extends beyond clinical practice, as he has established himself as a physician, writer, entrepreneur, and healthcare company executive.
At REGEnLIFE, Dr. Cristofini leads the company's efforts in pioneering medical technology that targets the brain-gut axis for treating neurodegenerative conditions. Under his leadership, REGEnLIFE has successfully raised €3 million in funding to advance its clinical trials on Alzheimer's disease and concussions, with results from a pilot study on concussions.
Dr. Cristofini's vision for REGEnLIFE includes developing therapeutic solutions for neurological diseases, particularly focusing on the potential beneficial effects of combining different light sources to address brain inflammation. His work at REGEnLIFE demonstrates his commitment to advancing medical science and improving patient outcomes in the field of neurodegenerative disorders.
Loading